Transplantation
At a glance...
|
Publications
“Clinical impact and health economic consequences of posttransplant diabetes mellitus” (modeling study) “Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients” (economic analysis) “Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective” (economic analysis) “Lymphomas after solid organ transplantation” (registry study) “Cytomegalovirus prophylaxis and solid organ transplantation” (registry study) “Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil” (outcomes and economics registry study) “Resource use and costs in kidney transplantation: impact of demographic factors, comorbidities, and complications” (economic analysis) “Pharmacoeconomic value of cyclosporine C2 monitoring” (telelecture) “Hospitalization days due to major cardiac events (mace) in de novo heart transplant recipients: results from a 12-month, multicenter, randomized trial of everolimus versus mycophenolate mofetil” (outcomes study) “Everolimus and reduced-exposure cyclosporine in de novo renal transplant recipients: a 3-year phase II randomized, multicenter, open-label study” (clinical trial) “Long-term prospective study of steroid withdrawal after kidney or heart transplantation“ (registry study) “Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplant recipients: 24-month results” (clinical trial) “Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial” (clinical trial) “Improved long-term outcomes after renal transplantation associated with blood pressure control” (registry study) “Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients” (clinical trial) “Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients” (clinical trial) “Long-term efficacy and safety of everolimus in cardiac transplantation” (clinical trial) Several abstracts and posters on Neoral, C2 monitoring, pharmacoeconomics Scientific advisory board slides for extended release tacrolimus in renal and liver transplantation Detailed outlines for a supplement on extended release tacrolimus |
Back to Areas of Expertise